BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12140733)

  • 1. In vivo selective expansion of gene-modified hematopoietic cells in a nonhuman primate model.
    Hanazono Y; Nagashima T; Takatoku M; Shibata H; Ageyama N; Asano T; Ueda Y; Dunbar CE; Kume A; Terao K; Hasegawa M; Ozawa K
    Gene Ther; 2002 Aug; 9(16):1055-64. PubMed ID: 12140733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo expansion of gene-modified hematopoietic cells by a novel selective amplifier gene utilizing the erythropoietin receptor as a molecular switch.
    Nagashima T; Ueda Y; Hanazono Y; Kume A; Shibata H; Ageyama N; Terao K; Ozawa K; Hasegawa M
    J Gene Med; 2004 Jan; 6(1):22-31. PubMed ID: 14716674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A selective amplifier gene for tamoxifen-inducible expansion of hematopoietic cells.
    Xu R; Kume A; Matsuda KM; Ueda Y; Kodaira H; Ogasawara Y; Urabe M; Kato I; Hasegawa M; Ozawa K
    J Gene Med; 1999; 1(4):236-44. PubMed ID: 10738556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction of the green fluorescent protein gene into hematopoietic stem cells results in prolonged discrepancy of in vivo transduction levels between bone marrow progenitors and peripheral blood cells in nonhuman primates.
    Hanazono Y; Terao K; Shibata H; Nagashima T; Ageyama N; Asano T; Ueda Y; Kato I; Kume A; Hasegawa M; Ozawa K
    J Gene Med; 2002; 4(5):470-7. PubMed ID: 12221639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion of genetically corrected neutrophils in chronic granulomatous disease mice by cotransferring a therapeutic gene and a selective amplifier gene.
    Hara T; Kume A; Hanazono Y; Mizukami H; Okada T; Tsurumi H; Moriwaki H; Ueda Y; Hasegawa M; Ozawa K
    Gene Ther; 2004 Sep; 11(18):1370-7. PubMed ID: 15229634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene transfer into nonhuman primate hematopoietic stem cells: implications for gene therapy.
    Hanazono Y; Terao K; Ozawa K
    Stem Cells; 2001; 19(1):12-23. PubMed ID: 11209087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of retroviral transduction efficiency in CD34+ cells derived from bone marrow versus G-CSF-mobilized or G-CSF plus stem cell factor-mobilized peripheral blood in nonhuman primates.
    Hematti P; Tuchman S; Larochelle A; Metzger ME; Donahue RE; Tisdale JF
    Stem Cells; 2004; 22(6):1062-9. PubMed ID: 15536196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo expansion of transduced murine hematopoietic cells with a selective amplifier gene.
    Kume A; Koremoto M; Xu R; Okada T; Mizukami H; Hanazono Y; Hasegawa M; Ozawa K
    J Gene Med; 2003 Mar; 5(3):175-81. PubMed ID: 12666183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients.
    Cowan KH; Moscow JA; Huang H; Zujewski JA; O'Shaughnessy J; Sorrentino B; Hines K; Carter C; Schneider E; Cusack G; Noone M; Dunbar C; Steinberg S; Wilson W; Goldspiel B; Read EJ; Leitman SF; McDonagh K; Chow C; Abati A; Chiang Y; Chang YN; Gottesman MM; Pastan I; Nienhuis A
    Clin Cancer Res; 1999 Jul; 5(7):1619-28. PubMed ID: 10430060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a modified selective amplifier gene for hematopoietic stem cell gene therapy.
    Matsuda KM; Kume A; Ueda Y; Urabe M; Hasegawa M; Ozawa K
    Gene Ther; 1999 Jun; 6(6):1038-44. PubMed ID: 10455406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent low-level engraftment of rhesus peripheral blood progenitor cells transduced with the fanconi anemia C gene after conditioning with low-dose irradiation.
    Kang EM; Hanazano Y; Frare P; Vanin EF; De Witte M; Metzger M; Liu JM; Tisdale JF
    Mol Ther; 2001 Jun; 3(6):911-9. PubMed ID: 11407905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial transplantations in nonobese diabetic/severe combined immunodeficiency mice of transduced human CD34+ cord blood cells: efficient oncoretroviral gene transfer and ex vivo expansion under serum-free conditions.
    Gammaitoni L; Lucchi S; Bruno S; Tesio M; Gunetti M; Pignochino Y; Migliardi G; Lazzari L; Aglietta M; Rebulla P; Piacibello W
    Stem Cells; 2006 May; 24(5):1201-12. PubMed ID: 16410386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow gene transfer in three patients with adenosine deaminase deficiency.
    Hoogerbrugge PM; van Beusechem VW; Fischer A; Debree M; le Deist F; Perignon JL; Morgan G; Gaspar B; Fairbanks LD; Skeoch CH; Moseley A; Harvey M; Levinsky RJ; Valerio D
    Gene Ther; 1996 Feb; 3(2):179-83. PubMed ID: 8867866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.
    Kikuchi J; Mimuro J; Ogata K; Tabata T; Ueda Y; Ishiwata A; Kimura K; Takano K; Madoiwa S; Mizukami H; Hanazono Y; Kume A; Hasegawa M; Ozawa K; Sakata Y
    J Gene Med; 2004 Oct; 6(10):1049-60. PubMed ID: 15386735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of oncoretrovirally transduced hematopoietic stem cells and correction through ex vivo expansion.
    Bryder D; Björgvinsdóttir H; Sasaki Y; Jacobsen SE
    J Gene Med; 2005 Feb; 7(2):137-44. PubMed ID: 15538726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo gene marking of rhesus macaque long-term repopulating hematopoietic cells using a VSV-G pseudotyped versus amphotropic oncoretroviral vector.
    Shi PA; De Angioletti M; Donahue RE; Notaro R; Luzzatto L; Dunbar CE
    J Gene Med; 2004 Apr; 6(4):367-73. PubMed ID: 15079811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abrogation of TGF-beta activity during retroviral transduction improves murine hematopoietic progenitor and repopulating cell gene transfer efficiency.
    Yu J; Soma T; Hanazono Y; Dunbar CE
    Gene Ther; 1998 Sep; 5(9):1265-71. PubMed ID: 9930329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-level in vivo gene marking after gene-modified autologous hematopoietic stem cell transplantation without marrow conditioning in nonhuman primates.
    Ueda K; Hanazono Y; Shibata H; Ageyama N; Ueda Y; Ogata S; Tabata T; Nagashima T; Takatoku M; Kume A; Ikehara S; Taniwaki M; Terao K; Hasegawa M; Ozawa K
    Mol Ther; 2004 Sep; 10(3):469-77. PubMed ID: 15336647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retroviral vectors containing a variant dihydrofolate reductase gene for drug protection and in vivo selection of hematopoietic cells.
    Allay JA; Galipeau J; Blakley RL; Sorrentino BP
    Stem Cells; 1998; 16 Suppl 1():223-33. PubMed ID: 11012166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction of a xenogeneic gene via hematopoietic stem cells leads to specific tolerance in a rhesus monkey model.
    Heim DA; Hanazono Y; Giri N; Wu T; Childs R; Sellers SE; Muul L; Agricola BA; Metzger ME; Donahue RE; Tisdale JF; Dunbar CE
    Mol Ther; 2000 Jun; 1(6):533-44. PubMed ID: 10933978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.